Trending...
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
TAMPA, Fla. - ncarol.com -- Angels for Change, a global non-profit on a mission to end drug shortages, presented the organization's 2024 Drug Shortage Guardian Award to Fresenius Kabi USA, a health care company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition.
Fresenius Kabi USA received the award in recognition of its exceptional teamwork and patient focus during the critical chemotherapy shortages of 2023. The patient-centric focus and culture of Fresenius Kabi enabled the company to rapidly increase output and urgently steward emergency supply to thousands of customers and patients in need of critical therapies.
The Drug Shortage Guardian Award is presented annually to an organization and its people for exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a "defender; one who guards, protects those in need."
"It is important to recognize individuals within the supply chain for extraordinary, patient-focused work. In highlighting gold-standard work we foster change and support building the resilient supply chain of the future. We are proud to present our 2024 Guardian Award to Fresenius Kabi and its amazing employees who tirelessly strive to ensure patient access to lifesaving medicines across the country, even in dire shortage situations," said Founder and Chief Change Maker of Angels for Change, Laura Bray.
More on ncarol.com
In addition to recognizing Fresenius Kabi USA, Angels for Change also presented individual Drug Shortage Guardian Awards to two Fresenius employees: Karen Twardzik, Vice President, Customer Service Operations, and Danielle Gross, Manager, Customer Service.
These guardians' extraordinary work and leadership exceeded their normal tasks to navigate within the supply chain to ensure life-saving medicines were delivered to customers and patients experiencing dire shortages. Their heroic efforts helped save lives across the nation.
"At Fresenius Kabi, we exist to put lifesaving medicines and technologies in the hands of people who care for patients. We are honored to receive this recognition from Angels for Change and look forward to supporting the important work of Laura and the mission of Angels for Change. We will continue to do our part to put an end to essential medicine (or drug) shortages," said John Ducker, president and CEO, Fresenius Kabi, Region U.S.
The awards were presented at Fresenius Kabi's U.S. headquarters in Lake Zurich, Ill. on May 16th, 2024. Fresenius Kabi USA leadership and employees joined Angels for Change founder Laura Bray during the award presentation. Following this meeting another presentation occurred at nearby Melrose Park, Ill. where Fresenius Kabi operates a state-of-the art sterile injectable manufacturing site. Here, Bray presented a guardian award to Fresenius Kabi frontline workers who have worked tirelessly to increase supply of needed medicines for patients.
More on ncarol.com
About Angels for Change
Angels for Change is a volunteer-supported, global, 501c3 organization started in Tampa, Fla. that is on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced three life-saving drug shortages in nine months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages.
www.angelsforchange.org
About Fresenius Kabi USA
Fresenius Kabi, an operating company of Fresenius, is a global healthcare organization that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used for the therapy and care of patients with critical and chronic conditions. The company is actively involved in efforts to end drug shortages, has invested nearly a billion dollars in U.S. pharmaceutical manufacturing and distribution, and is a past recipient of a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. www.fresenius-kabi.com/us/
Fresenius Kabi USA received the award in recognition of its exceptional teamwork and patient focus during the critical chemotherapy shortages of 2023. The patient-centric focus and culture of Fresenius Kabi enabled the company to rapidly increase output and urgently steward emergency supply to thousands of customers and patients in need of critical therapies.
The Drug Shortage Guardian Award is presented annually to an organization and its people for exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a "defender; one who guards, protects those in need."
"It is important to recognize individuals within the supply chain for extraordinary, patient-focused work. In highlighting gold-standard work we foster change and support building the resilient supply chain of the future. We are proud to present our 2024 Guardian Award to Fresenius Kabi and its amazing employees who tirelessly strive to ensure patient access to lifesaving medicines across the country, even in dire shortage situations," said Founder and Chief Change Maker of Angels for Change, Laura Bray.
More on ncarol.com
- CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
- Q2 2025 Industry Impact Report Underscores Semiconductor Expansion, Talent Development and Sustainability Milestones
- 84 Ethiopian Churches Change Signboards to Shincheonji Church of Jesus
- BTXSGG Outlines Four-Pillar Framework to Enhance Digital Asset Security and Compliance
- NJTRX Positions for Next-Generation Asset Trading with U.S. Regulatory Framework
In addition to recognizing Fresenius Kabi USA, Angels for Change also presented individual Drug Shortage Guardian Awards to two Fresenius employees: Karen Twardzik, Vice President, Customer Service Operations, and Danielle Gross, Manager, Customer Service.
These guardians' extraordinary work and leadership exceeded their normal tasks to navigate within the supply chain to ensure life-saving medicines were delivered to customers and patients experiencing dire shortages. Their heroic efforts helped save lives across the nation.
"At Fresenius Kabi, we exist to put lifesaving medicines and technologies in the hands of people who care for patients. We are honored to receive this recognition from Angels for Change and look forward to supporting the important work of Laura and the mission of Angels for Change. We will continue to do our part to put an end to essential medicine (or drug) shortages," said John Ducker, president and CEO, Fresenius Kabi, Region U.S.
The awards were presented at Fresenius Kabi's U.S. headquarters in Lake Zurich, Ill. on May 16th, 2024. Fresenius Kabi USA leadership and employees joined Angels for Change founder Laura Bray during the award presentation. Following this meeting another presentation occurred at nearby Melrose Park, Ill. where Fresenius Kabi operates a state-of-the art sterile injectable manufacturing site. Here, Bray presented a guardian award to Fresenius Kabi frontline workers who have worked tirelessly to increase supply of needed medicines for patients.
More on ncarol.com
- Poncho Tha Popstar: The West's Next King
- Physician-Turned-Patient Launches Advocacy Campaign to Spotlight Disability Insurance Barriers
- Thorn Ridge® Creates a World of Legends & Lore
- Twice the Laughs: Comedy Star Don Barnhart Rotates Residency at Both Delirious Comedy Club Locations in Las Vegas
- Your Body Isn't Broken—It's Out of Balance: The New Book Revealing the Blueprint to Restore Hormone Balance, Sleep, Gut & Metabolic Health
About Angels for Change
Angels for Change is a volunteer-supported, global, 501c3 organization started in Tampa, Fla. that is on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced three life-saving drug shortages in nine months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages.
www.angelsforchange.org
About Fresenius Kabi USA
Fresenius Kabi, an operating company of Fresenius, is a global healthcare organization that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used for the therapy and care of patients with critical and chronic conditions. The company is actively involved in efforts to end drug shortages, has invested nearly a billion dollars in U.S. pharmaceutical manufacturing and distribution, and is a past recipient of a Drug Shortage Assistance Award from the U.S. Food and Drug Administration. www.fresenius-kabi.com/us/
Source: AngelsForChange.org
0 Comments
Latest on ncarol.com
- Where the Miami Dolphins Stand After Week 1
- Which NFL Teams Can Rebound from Week 1? OddsTrader Breaks Down the Biggest Questions
- Apellix Deploys Breakthrough Spray-Painting Drones into Live Service Limited Beta Program Open for Advanced Contractors
- Coming Up on the Podcast "Financial Freedom with Tom Hegna" Larry and Judy Poole
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- United Mitochondrial Disease Foundation Announces 2025 Energy For Life Walk – Charlotte
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- Entrinsicon 2025 Returns to Raleigh, Showcases AI and Data Innovation
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
- NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets
- Wzzph Analyzes Crypto Market Maturation as Institutional Capital Drives $50B ETF Inflows